Wacker Chemie AG increased its sales slightly for full-year 2018, as projected.
The Munich-based chemical group WACKER is increasing its global production capacities for silicone rubber.
As of November 1, 2018, the pharmaceutical protein production facility in the Netherlands acquired by WACKER with its takeover of SynCo Bio Partners Luxembourg S.à r.l., will be renamed Wacker Biotech B.V.
Thanks to the strong performance of its chemical business, Wacker Chemie AG’s sales and EBITDA continued to grow in the second quarter of 2018, both year over year and quarter over quarter.
WACKER BIOSOLUTIONS, the life sciences division of the WACKER Group, has begun producing fermentation-generated cystine at its new site in León, Spain.